Table 6 Therapy for Moderate/Severe Pain Comparison between the two audits
Audit YEAR | 2016 | 2020 | p-value |
|---|---|---|---|
Patients n | 75 | 63 | Â |
Patients with M/S P | 32 (43%) | 32 (55%) | 0.131 |
Mean value PMI | − 0.8 | -1.3 | 0.011 |
Standard Deviation PMI | ± 1.3 | ± 0,9 |  |
Minimum PMI | − 3 | -3 |  |
Maximum PMI | + 2 | 0 |  |
PMI < 0 (undertreated Pain) | 60%(45/75) | 87%(55/63) | < 0.001 |
PMI ≥ 0 | 40%(30/75) | 13%(8/63) |  |
Time Based therapy | 44%(33/75) | 63%(40/63) | 0.038 |
Intermittent Therapy | 25%(40/75) | 22%(14/63) | Â |
No Therapy | 31%(23/75) | 15%(9/63) | Â |
Multimodal Analgesia | 23%(17/75) | 13%(8/63) | 0.130 |